首页> 外文期刊>Journal of the American Chemical Society >Solution NMR Spectroscopy of the Human Vasopressin V2 Receptor,A G Protein-Coupled Receptor
【24h】

Solution NMR Spectroscopy of the Human Vasopressin V2 Receptor,A G Protein-Coupled Receptor

机译:人加压素V2受体,G蛋白偶联受体的溶液NMR光谱

获取原文
获取原文并翻译 | 示例
           

摘要

The human genome encodes at least 800 unique G protein-coupled receptors (GPCRs),which share a common membrane topology of seven transmembrane segments.GPCRs serve as the primary sensors for human olfaction,taste,and vision,play a host of critical roles in human physiology,and are the targets for a substantial fraction of all known drugs.Despite their importance,only a single high-resolution structure of a GPCR has been determined,that of the dark (signaling-off) state of the bovine photoreceptor,rhodopsin,first solved by X-ray crystallographic methods in 2000.While solution NMR spectroscopy is now established as a method for determining the structures of polytopic membrane proteins,the feasibility of approaching the structures of GPCRs by this method has not been clear.Previous solution NMR applications to GPCRs have been limited to (i) characterization of GPCR fragments and isolated extramembrane domains,(ii) examination of ligands bound to GPCRs,and (iii) probes of selectively labeled rhodopsin to address specific structural,dynamic,and mechanistic issues (see also refs 22 and 23).Here,results are presented for a uniformly isotopically labeled GPCR that indicate a promising outlook for application of solution NMR methods to structural studies of intact receptors.
机译:人类基因组编码至少800个独特的G蛋白偶联受体(GPCR),它们共有七个跨膜段的共同膜拓扑结构.GPCR是人类嗅觉,味觉和视觉的主要传感器,在人类嗅觉,味觉和视觉中起着关键作用人类生理,并且是所有已知药物的相当一部分的靶标。尽管其重要性,但仅测定了GPCR的单个高分辨率结构,即牛感光体的暗态(信号传递),视紫红质。在2000年首次通过X射线晶体学方法解决。虽然现在建立了溶液NMR光谱法来测定多聚膜蛋白的结构,但尚不清楚采用该方法接近GPCR的结构的可行性。 GPCR的应用仅限于(i)GPCR片段和分离的膜外结构域的表征,(ii)与GPCR结合的配体的检测以及(iii)选择性标记的探针视紫红质的研究,以解决特定的结构,动力学和机制问题(另请参见参考文献22和23)。在此,给出了同位素标记均一的GPCR的结果,这些结果表明溶液NMR方法在完整受体的结构研究中的应用前景广阔。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2005年第22期|p.8010-8011|共2页
  • 作者单位

    Center for Structural Biology and Departments of Biochemistry and Pharmacology,Vanderbilt University School of Medicine,Nashville,Tennessee 37232-8725;

    Center for Structural Biology and Departments of Biochemistry and Pharmacology,Vanderbilt University School of Medicine,Nashville,Tennessee 37232-8725;

    Center for Structural Biology and Departments of Biochemistry and Pharmacology,Vanderbilt University School of Medicine,Nashville,Tennessee 37232-8725;

    Center for Structural Biology and Departments of Biochemistry and Pharmacology,Vanderbilt University School of Medicine,Nashville,Tennessee 37232-8725;

    Center for Structural Biology and Departments of Biochemistry and Pharmacology,Vanderbilt University School of Medicine,Nashville,Tennessee 37232-8725;

    Center for Structural Biology and Departments of Biochemistry and Pharmacology,Vanderbilt University School of Medicine,Nashville,Tennessee 37232-8725;

    Center for Structural Biology and Departments of Biochemistry and Pharmacology,Vanderbilt University School of Medicine,Nashville,Tennessee 37232-8725;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号